Elixir Pharmaceuticals Inc is a Wholesale Pharmaceutical Products business in Cambridge, MA.
| Business Name: | Elixir Pharmaceuticals Inc |
| Categorized In: | Wholesale Pharmaceutical Products |
| Address: | 320 Putnam Avenue, Cambridge, MA 02139 |
| Phone Number: | (617) 995-7000 |
| Contact Person: | Paul Martha, Chief Executive Officer |
| NAICS Code: | 4242101 |
| SIC Code: | 5122 |
| Business Type: | B2B (Business to Business) |
| Employee #: | 1 to 4 |
| Location Type: | Single Location |
| Annual Revenue ($): | $50.000.000 to $99.999.999 |
| Share This Business: | |
| Similar Businesses: |
Algeta Us LLC - Cambridge, MA 02139 Sante Fe Pester Biologic - Cambridge, MA 02139 Shire Pharmaceuticals - Cambridge, MA 02139 Novartis Pharmaceuticals - Cambridge, MA 02139 Catabasis Pharmaceutical - Cambridge, MA 02139 S Ken Tanaka - Cambridge, MA 02139 Sanofi US - Cambridge, MA 02139 Akceli Inc - Cambridge, MA 02139 Interneuron Pharmaceuticals - Cambridge, MA 02139 |
Elixir Pharmaceuticals Inc, a stable growing company under Wholesale Pharmaceutical Products, is being run by Paul Martha, Chief Executive Officer. Since , their sales have been favorable and consistent at $50.000.000 to $99.999.999. Company location coordinates are: 42.36156,-71.11335.
It can be reached by dialing (617) 995-7000, and you could get in touch with their sales team in 320 Putnam Avenue, Cambridge, Massachusetts MA 02139. Visit their website at: to know more about the company’s history, products and services, as well as frequently asked questions and privacy policies.
Special deals are also offered from time to time. Their professional and honest business transactions fortifies both consumers and businesses in their B2B segments.
Their modest but solid single location houses 1 to 4 staff members. All are benefiting from the company’s generous programs and sound training solutions.
You can learn more by checking their classification codes: SIC – 5122 and NAIC – 4242101. Call the hotline stated above for faster transaction and queries. Elixir Pharmaceuticals Inc would like to hear from you.